Renaissance Technologies’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $844K | Buy |
114,008
+80,411
| +239% | +$595K | ﹤0.01% | 2592 |
|
|
2025
Q1 | $289K | Buy |
33,597
+9,346
| +39% | +$80.4K | ﹤0.01% | 2938 |
|
|
2024
Q4 | $867K | Buy |
24,251
+4,542
| +23% | +$162K | ﹤0.01% | 2575 |
|
|
2024
Q3 | $931K | Sell |
19,709
-38,220
| -66% | -$1.81M | ﹤0.01% | 2487 |
|
|
2024
Q2 | $2.91M | Buy |
57,929
+816
| +1% | +$41K | ﹤0.01% | 1630 |
|
|
2024
Q1 | $6.4M | Buy |
57,113
+22,484
| +65% | +$2.52M | 0.01% | 1254 |
|
|
2023
Q4 | $2.01M | Sell |
34,629
-2,408
| -7% | -$140K | ﹤0.01% | 1951 |
|
|
2023
Q3 | $1.18M | Sell |
37,037
-4,880
| -12% | -$155K | ﹤0.01% | 2191 |
|
|
2023
Q2 | $3.45M | Sell |
41,917
-8,104
| -16% | -$667K | 0.01% | 1640 |
|
|
2023
Q1 | $5.14M | Buy |
50,021
+27,152
| +119% | +$2.79M | 0.01% | 1463 |
|
|
2022
Q4 | $3.35M | Sell |
22,869
-5,084
| -18% | -$745K | ﹤0.01% | 1747 |
|
|
2022
Q3 | $4.72M | Buy |
27,953
+5,140
| +23% | +$869K | 0.01% | 1480 |
|
|
2022
Q2 | $2.64M | Sell |
22,813
-13,955
| -38% | -$1.61M | ﹤0.01% | 1993 |
|
|
2022
Q1 | $3.67M | Buy |
36,768
+23,064
| +168% | +$2.3M | ﹤0.01% | 1793 |
|
|
2021
Q4 | $2.13M | Buy |
+13,704
| New | +$2.13M | ﹤0.01% | 2096 |
|
|
2020
Q4 | – | Sell |
-2,860
| Closed | -$1.33M | – | 3599 |
|
|
2020
Q3 | $1.33M | Sell |
2,860
-10,751
| -79% | -$5M | ﹤0.01% | 2350 |
|
|
2020
Q2 | $7.96M | Sell |
13,611
-17,732
| -57% | -$10.4M | 0.01% | 1363 |
|
|
2020
Q1 | $4.57M | Buy |
31,343
+2,552
| +9% | +$372K | ﹤0.01% | 1619 |
|
|
2019
Q4 | $4.12M | Sell |
28,791
-1,878
| -6% | -$269K | ﹤0.01% | 1977 |
|
|
2019
Q3 | $1.21M | Buy |
30,669
+20,028
| +188% | +$791K | ﹤0.01% | 2517 |
|
|
2019
Q2 | $1.08M | Buy |
10,641
+3,660
| +52% | +$370K | ﹤0.01% | 2641 |
|
|
2019
Q1 | $918K | Buy |
+6,981
| New | +$918K | ﹤0.01% | 2709 |
|